HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes.

Abstract
We report the largest and most diverse genetic study of type 1 diabetes (T1D) to date (61,427 participants), yielding 78 genome-wide-significant (P < 5 × 10-8) regions, including 36 that are new. We define credible sets of T1D-associated variants and show that they are enriched in immune-cell accessible chromatin, particularly CD4+ effector T cells. Using chromatin-accessibility profiling of CD4+ T cells from 115 individuals, we map chromatin-accessibility quantitative trait loci and identify five regions where T1D risk variants co-localize with chromatin-accessibility quantitative trait loci. We highlight rs72928038 in BACH2 as a candidate causal T1D variant leading to decreased enhancer accessibility and BACH2 expression in T cells. Finally, we prioritize potential drug targets by integrating genetic evidence, functional genomic maps and immune protein-protein interactions, identifying 12 genes implicated in T1D that have been targeted in clinical trials for autoimmune diseases. These findings provide an expanded genomic landscape for T1D.
AuthorsCatherine C Robertson, Jamie R J Inshaw, Suna Onengut-Gumuscu, Wei-Min Chen, David Flores Santa Cruz, Hanzhi Yang, Antony J Cutler, Daniel J M Crouch, Emily Farber, S Louis Bridges Jr, Jeffrey C Edberg, Robert P Kimberly, Jane H Buckner, Panos Deloukas, Jasmin Divers, Dana Dabelea, Jean M Lawrence, Santica Marcovina, Amy S Shah, Carla J Greenbaum, Mark A Atkinson, Peter K Gregersen, Jorge R Oksenberg, Flemming Pociot, Marian J Rewers, Andrea K Steck, David B Dunger, Type 1 Diabetes Genetics Consortium, Linda S Wicker, Patrick Concannon, John A Todd, Stephen S Rich
JournalNature genetics (Nat Genet) Vol. 53 Issue 7 Pg. 962-971 (07 2021) ISSN: 1546-1718 [Electronic] United States
PMID34127860 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Copyright© 2021. Crown.
Topics
  • Alleles
  • Autoimmunity (genetics)
  • CD4-Positive T-Lymphocytes (immunology, metabolism)
  • Chromosome Mapping
  • Diabetes Mellitus, Type 1 (drug therapy, genetics, metabolism)
  • Drug Discovery
  • Gene Expression
  • Genetic Predisposition to Disease
  • Genetic Variation
  • Genomics (methods)
  • Humans
  • Molecular Targeted Therapy
  • Protein Interaction Mapping

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: